These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21839903)

  • 21. Is equity of access to health care achievable in Latin America?
    Araújo GT; Caporale JE; Stefani S; Pinto D; Caso A
    Value Health; 2011; 14(5 Suppl 1):S8-12. PubMed ID: 21839905
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of utilization and expenditures for episodes of ambulatory physical therapy among adults.
    Machlin SR; Chevan J; Yu WW; Zodet MW
    Phys Ther; 2011 Jul; 91(7):1018-29. PubMed ID: 21566066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Out-of-pocket health expenditure in a population covered by the Family Health Program in Brazil.
    Barros AJ; Bertoldi AD
    Int J Epidemiol; 2008 Aug; 37(4):758-65. PubMed ID: 18411201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relevance and financing of health services: a survey of physicians, students, patients, nursing personnel and seniors].
    Röstermundt A; Westphal R; Raspe H
    Gesundheitswesen; 2001 May; 63(5):311-8. PubMed ID: 11441674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.
    Orzella L; Chini F; Giorgi Rossi P; Borgia P
    Health Policy; 2010 May; 95(2-3):236-44. PubMed ID: 20047773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost of heart failure in the Unified Health System].
    Araujo DV; Tavares LR; Veríssimo R; Ferraz MB; Mesquita ET
    Arq Bras Cardiol; 2005 May; 84(5):422-7. PubMed ID: 15917977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The development of drug utilization with special reference to demographic factors].
    Mansky T; Erben CM; Reichelt H; Scriba PC
    Offentl Gesundheitswes; 1989 Oct; 51(10):592-8. PubMed ID: 2531309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, content and financing of an essential national package of health services.
    Bobadilla JL; Cowley P; Musgrove P; Saxenian H
    Bull World Health Organ; 1994; 72(4):653-62. PubMed ID: 7923544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of demographic changes on health care expenditure in Germany: an analysis considering the expenditures of decedents].
    Gandjour A; Ihle P; Schubert I
    Gesundheitswesen; 2008 Feb; 70(2):77-80. PubMed ID: 18348096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health resource allocation. A made-in-Canada description.
    Noseworthy T
    J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053
    [No Abstract]   [Full Text] [Related]  

  • 31. Public and private pharmaceutical spending as determinants of health outcomes in Canada.
    Crémieux PY; Meilleur MC; Ouellette P; Petit P; Zelder M; Potvin K
    Health Econ; 2005 Feb; 14(2):107-16. PubMed ID: 15386658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ
    Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical reform in South Korea and the lessons it provides.
    Kim HJ; Ruger JP
    Health Aff (Millwood); 2008; 27(4):w260-9. PubMed ID: 18508813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health system financing paradigm in the state of São Paulo: a regional analysis.
    Soares A
    Rev Saude Publica; 2019; 53():39. PubMed ID: 31066817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of disorders of the brain in Denmark.
    Olesen J; Sobscki P; Truelsen T; Sestoft D; Jönsson B
    Nord J Psychiatry; 2008; 62(2):114-20. PubMed ID: 18569774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expenditures on medicines by the Rio de Janeiro Municipal Health Department, Brazil, 2002-2011].
    Silva RM; Caetano R
    Cad Saude Publica; 2014 Jun; 30(6):1207-18. PubMed ID: 25099044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resource allocation for pharmaceutical procurement in the Brazilian Unified Health System.
    Vieira FS; Zucchi P
    Rev Saude Publica; 2011 Oct; 45(5):906-13. PubMed ID: 21808832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exceptional circumstance drug dispensing: history and expenditures of the Brazilian Ministry of Health.
    Carias CM; Vieira FS; Giordano CV; Zucchi P
    Rev Saude Publica; 2011 Apr; 45(2):233-40. PubMed ID: 21412568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the "Farmácia popular" program in Brazil: an interrupted time series study.
    Emmerick ICM; Campos MR; da Silva RM; Chaves LA; Bertoldi AD; Ross-Degnan D; Luiza VL
    BMC Public Health; 2020 Jan; 20(1):24. PubMed ID: 31914972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.